Unlocking pathology archives for molecular genetic studies: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization.
about
Complex landscapes of somatic rearrangement in human breast cancer genomes.Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug developmentAutomated array-CGH optimized for archival formalin-fixed, paraffin-embedded tumor material.Development of automated brightfield double in situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in situ hybridIntegrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets.Adjusting breast cancer patient prognosis with non-HER2-gene patterns on chromosome 17.The identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancerOut of the darkness and into the light: bright field in situ hybridisation for delineation of ERBB2 (HER2) status in breast carcinomaWhole genome sequencing of matched primary and metastatic acral melanomasFGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis.MYC amplification in breast cancer: a chromogenic in situ hybridisation studyFunctional characterization of the 19q12 amplicon in grade III breast cancersThe status of epidermal growth factor receptor in borderline ovarian tumours.Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancerImmunophenotypic and genomic characterization of papillary carcinomas of the breast.Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection.Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas.Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancerIntegrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies.Functional characterization of EMSY gene amplification in human cancers.c-KIT overexpression, without gene amplification and mutation, in paediatric renal tumours.A distinct spectrum of copy number aberrations in pediatric high-grade gliomas.Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis.Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers.Childhood papillary thyroid cancer as second malignancy after successful treatment of rhabdomyosarcoma.Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6'split apart' probes.Novel, gross chromosomal alterations involving PTEN cooperate with allelic loss in prostate cancer.Expression of p63 is the sole independent marker of aggressiveness in localised (stage I-II) Merkel cell carcinomas.
P2860
Q24631412-7767CAAA-DDFE-462B-BE14-504D2D8C1601Q28475285-AB497943-214B-4EC6-8102-EA2510AD1566Q33277286-05CBAFF0-398C-4431-8122-27069E8CA1B4Q33378811-B5458094-F816-499B-BB56-AEED1EB30B1FQ33780945-960C0285-5A76-4B94-A552-0AFE7768FB1DQ34010867-88653D1C-D2E6-4B30-A305-6D87E0A344B4Q34050388-8FC0037D-12CE-4B9A-B813-2D888F4857FBQ34064466-4F62A9DF-EAC6-4E13-A937-A238C41D0A0FQ34241728-7AFD7D9F-6716-45A4-909B-FA1EB98EBBA7Q35794378-F21B4916-A8C1-4BC7-B9DD-6B0182BD0A41Q35984487-559A486C-BC8C-42AE-96E0-14A625E7E81DQ36245567-84EB70D5-0D51-44EE-B36F-19834351E242Q36963030-50D60151-BB44-4081-9A26-DF1EBEABA9B5Q37107560-05A32EC9-51F4-47C9-AB5E-1549F99D3E7BQ37130628-144C97E3-8967-40DE-B442-F4DE80ED5140Q37155717-D0A1C5EA-E84F-4353-B720-A7C4934103FEQ37345320-8DF56B5A-82B1-452A-BC2D-720126E57556Q37701538-451F10A5-403A-43D7-95C5-174EFE124522Q39207741-DEA6EA59-E1D2-4CF8-906E-6B42E159894BQ39511351-9AECB8E6-B150-4C1E-BB95-14239E2244EBQ40684923-CAC25658-496C-41BE-A4CC-591BE344828AQ41943655-327D7335-03D9-420C-9B8A-1C812B7DBC6DQ42494164-51450ED9-6C78-4730-B1F2-7A79AF39581AQ42496315-5E17D973-9B18-4DE8-85C4-C38EF7DA295FQ46695782-3EDA6A27-5C42-4471-9003-5D00F48CE655Q48683902-7EE745C8-4DF6-4B2B-8AC7-D7BC4A29B756Q52623792-CC1E48FB-E1C6-4A1A-A3F5-95BC34CBE3FAQ54359016-41FCCD03-BA91-4260-93B7-0B7FDD6FD6C3
P2860
Unlocking pathology archives for molecular genetic studies: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Unlocking pathology archives f ...... rescent in situ hybridization.
@ast
Unlocking pathology archives f ...... rescent in situ hybridization.
@en
Unlocking pathology archives f ...... rescent in situ hybridization.
@nl
type
label
Unlocking pathology archives f ...... rescent in situ hybridization.
@ast
Unlocking pathology archives f ...... rescent in situ hybridization.
@en
Unlocking pathology archives f ...... rescent in situ hybridization.
@nl
prefLabel
Unlocking pathology archives f ...... rescent in situ hybridization.
@ast
Unlocking pathology archives f ...... rescent in situ hybridization.
@en
Unlocking pathology archives f ...... rescent in situ hybridization.
@nl
P2093
P2860
P50
P1476
Unlocking pathology archives f ...... rescent in situ hybridization.
@en
P2093
Alan Mackay
Charlotte Westbury
Chris Jones
Dawn Steele
Kay Savage
Maryou B K Lambros
Pete T Simpson
P2860
P2888
P304
P356
10.1038/LABINVEST.3700390
P577
2006-04-01T00:00:00Z
P5875
P6179
1048816971